What is Thymia?
Thymia operates as a pioneering health technology firm dedicated to revolutionizing mental health assessment. The company utilizes proprietary gamified AI tools that analyze voice, movement, and behavioral patterns to detect symptoms of mental illness with high precision. By moving away from subjective self-reporting, Thymia provides clinicians with actionable, objective data, thereby facilitating earlier interventions and more personalized treatment plans. This technological framework addresses a critical gap in the current healthcare landscape, where diagnostic accuracy remains a significant challenge for providers and patients alike.
How much funding has Thymia raised?
Thymia has raised a total of $2.7M across 1 funding round:
Angel/Seed
$2.7M
Angel/Seed (2023): $2.7M with participation from Entrepreneur First and Form Ventures
Key Investors in Thymia
Entrepreneur First
Entrepreneur First is an international talent investor that supports high-potential individuals in building scalable technology companies from the ground up.
Form Ventures
Form Ventures is an investment firm specializing in UK startups, particularly those navigating complex regulatory landscapes and public policy environments.
What's next for Thymia?
With this major strategic investment, Thymia is well-positioned to scale its operations and accelerate the clinical validation of its diagnostic platform. The company is expected to focus on expanding its reach within the enterprise healthcare market, potentially integrating its behavioral analysis tools into broader clinical workflows. As the firm transitions from its early-stage development phase, the focus will likely shift toward regulatory compliance and strategic partnerships with healthcare providers, ensuring that its AI-driven solutions are seamlessly adopted in clinical settings to improve patient outcomes on a global scale.
See full Thymia company page
